Yahoo · Oct 28, 2026
ASP Isotopes Targets $300M EBITDA as Helium, Silicon-28 and Radiopharmacy Plans Advance
ASP Isotopes (NASDAQ:ASPI) CEO Paul Mann outlined the company’s plans to expand its isotope-enrichment, radiopharmacy and helium businesses, while targeting more than $300 million in EBITDA by 2031. Speaking at the Emerging Growth Conference, Mann said the company has built three manufacturing plan

